Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1

Journal of Periodontology

Volumn 67, Issue 2, 1996, Pages 116-124

  Johnson, Georgia K ^a,c   Poore, Thomas K ^a   Payne, Jeffrey B ^b   Organ, Connie C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

gingival recession etiology; interleukin 1; keratinocytes metabolism; mucosal diseases etiology; prostaglandin; tobacco, smokeless adverse effects

Indexed keywords

INTERLEUKIN 1; PROSTAGLANDIN E2;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; KERATINOCYTE; PERIODONTAL DISEASE; SMOKING; TOBACCO;

EID: 0029892376     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.2.116     Document Type: Article

References (43)

1. Robertson PB, Walsh M, Greene J, Ernster V, Grady D, Hauck W. Periodontal effects associated with the use of smokeless tobacco. J Periodontol 1990,61:438-443.
2. Greer PO, Poulson TC. Oral tissue alterations associated with the use of smokeless tobacco by teen-agers. Part I. Clinical findings. Oral Surg Oral Med Oral Pathol 1983;56.275-284
3. Poulson TC, Lindenmuth JE, Greer RO Jr. A comparison of the use of smokeless tobacco in rural and urban teenagers. CA 1984;34.248-261.
4. Offenbacher S, Weathers DR. Effect of smokeless tobacco on the periodontal, mucosal and caries status of adolescent males. J Oral Parhol 1985;14:169-181.
5. Hirsch JM, Heyden G, Thilander H A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J Oral Pathol 1982;11:387-398.
6. Pindborg JJ, Renstrup G. Studies in oral leukoplakias. II. Effect on oral epithelium. Acta Dermato-Venereologica 1963;43:271-276.
7. Axell T, Mornstad H, Sundstrom B. The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. J Oral Pathol 1976;5:229-236
8. Frithiof L, Anneroth G, Lasson U, Sederholm C. The snuff-induced lesion A clinical and morphological study of a Swedish material. Acta Odontol Scand 1983;41:53-64.
9. Andersson G, Axell T, Larsson A. Histologic changes associated with the use of loose and portion-bag packed Swedish moist snuff: A comparative study. J Oral Pathol 1989;18:491-497.
10. Daniels TE, Hansen LS, Greenspan JS, et al. Histopathology of smokeless tobacco lesions in professional baseball players: Associations with different types of tobacco. Oral Sarg Oral Med Oral Pathol 1992;73:720-725.
11. 2 and interleukin-1 levels in smokeless-tobacco induced oral mucosal lesions. J Periodont Res 1994;29:430-438.
12. Kupper TS. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 1990;86:1783-1789.
13. Luger TA, Schwarz T. Epidermal cytokines. In: Bos J, ed. Skin Immune System. CRC Press. Boca Raton; 1990:257-292.
14. Kupper TS. The role of epidermal cytokines. In: Shevach E, Oppenheim J, eds. Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation. New York: Oxford University Press; 1990:285-305.
15. Sauder DN, Stanuhs-Praeger BM, Gilchrist BA. Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thyinocyte-activating factor: implications for skin aging. Arch Dermatol Res 1988;280:71-76.
16. Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991;62:504-509.
17. Tatakis DM. Interleukin-1 and bone metabolism: A review. J Periodontol 1993;64:416-431.
18. Pentland AP, Mahoney MG. Keratinocyte prostaglandin synthesis is enhanced by IL-1. J Invest Dermatol 1990;94:43-46.
19. 2α on epidermal growth. Arch Dermatol Res 1977,257:233-237.
20. Bem JL, Greaves MW. Prostaglandin El effects on epidermal cell growth "in vitro." Arch Dermatol Forsch 1974;251:35-41.
21. Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE, secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
22. Pentland AP, Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis J Clin Invest 1986;77:246-251.
23. Rheinwald JG, Green H Serial cultivation of strains of human epidermal keratinocytes: The formation of colonies from single cells. Cell 1975;6:331-343
24. Lindemann RA, Park N-H. Inhibition of human lymphokine-activated killer activity by smokeless tobacco (snuff) extract. Arch Oral Biol 1988;33:317-321
25. Hoffmann D, Adams J. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Canc Res 1981;41: 4305-4308.
26. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem 1986;55:69-102.
27. 2 and IL-1β. J Periodontol 1994;65:937-941.
28. Furstenberger G, Gross M, Marks F. On the role of prostaglandins in the induction of epidermal proliferation, hyperplasia and tumor promotion in mouse skin. In: Powlles TJ, Bockman RS, Honn KV, Ramwell P, eds Prostaglandins and Cancer: First International Conference, Vol 2: Prostaglandins and Related Lipids. New York: Alan R. Liss; 1982.239-254.
29. McCullough JL, Schreiber SH, Ziboh VA. Cell proliferation kinetics of epidermis in the essential fatty acid deficient rat. J Invest Dermatol 1978;70:318-320
30. Pentland AP, George J, Moran C, Needleman P. Cellular confluence determines injury-induced prostaglandin E, synthesis by human keratinocyte cultures. Biochem Biophys Acta 1987;919:71-78.
31. Johnson GK, Organ CC. Effect of smokeless tobacco on arachidonic acid metabolites in rat oral mucosa. J Dent Res 1995;74.(Spec. Issue)20(Abstr. 68).
32. Ringdahl B, Ali RB, Johnson GK, Organ CC. Effect of topical nicotine on arachidonic acid metabolites and histological parameters in rat oral mucosa. (1994 Orban Competition and Research Forum Abstracts). J Periodontol 1994;65:986.
33. Wu Wang CY, Wang S-L, Brigham M, Correa A, Slomiany A, Slomiany BL. Expression of prostaglandin E, receptor in hamster buccal pouch: Effect of benzo(A) pyrene and nicotine. Prostaglandins, Leukot Essent Fatty Acids 1993;49:821-826.
34. Wennmalm A. Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis. Br J Pharmac 1978;64:559-563.
35. Wennmalm A, Alster P. Nicotine inhibits vascular prostacyclin but not platelet thromboxane formation. Gen Pharmac 1983;14:189-191.
36. Nadler JL, Velasco JS, Horton R. Cigarette smoking inhibits prostacyclin formation. Lancet 1983;(June 4):1248-1250.
37. Francus T, Romano PM, Manzo G, Fonacier L, Arango CN, Szabo P. IL-1, IL-6 and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cellular Immunol 1992;145:156-174.
38. Dinarello CA, Savage N. Interleukin-1 and its receptor. Crit Rev Immunol 1989;9:1-20.
39. Squier CA, Johnson GK. Role of nicotine as a cofactor in smokeless tobacco carcinogenesis. Smoking and Tobacco Control Monograph 2: Smokeless tobacco or health, an international perspective. National Cancer Institute, 1992:153-160. NIH publication no. 92-3461.
40. Russell MAH, Jarvis MJ, Devitt G. Fejerabend C. Nicotine intake by snuff users. Br Med J 1981;283:814-817.
41. Tilashalski K, Rodu B, Mayfield C. Assessing the nicotine content of smokeless tobacco products. J Am Dent Assoc 1994;125:590-594.
42. Kupper TS, Ballard C, Chua AO, et al. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and β mRNA. J Exp Med 1986;164:2095-2100.
43. Gruaz-Chatellard D, Baumberger C, Saurat J-H, Dayer M.-M. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS 1991;294:137-140.